IndexNo:810188:bEqJstdNduAZ
| 投稿者 | Camila |
|---|---|
| 投稿日時 | 2014/08/11 22:13:44 |
| A company car http://www.computerrepairleeds.co.uk/mac-repairs-leeds cost celebrex McHutchison said data on another Gilead all-oral regimen - sofosbuvir combined with NS5A inhibitor ledipasvir - will be presented at a medical meeting next April. The company plans to file for FDA approval of that regimen, which includes genotype 1 patients, in the first half of next year. | |